Spontaneous immune responses to sporadic tumors: Tumor-promoting, tumor-protective or both?

Cancer Immunology, Immunotherapy

Volumn 57, Issue 10, 2008, Pages 1531-1539

  De Visser, Karin E ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Adaptive immune system; Cancer; Immunosurveillance; Inflammation; Innate immune system

Indexed keywords

CANCER GROWTH; CARCINOGENESIS; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HEALTH PROMOTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MICROENVIRONMENT; PRIORITY JOURNAL; TUMOR IMMUNITY;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; IMMUNE TOLERANCE; NEOPLASMS; TUMOR ESCAPE;

EID: 48149104816     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-008-0501-x     Document Type: Conference Paper

References (50)

1. F Balkwill KA Charles A Mantovani 2005 Smoldering and polarized inflammation in the initiation and promotion of malignant disease Cancer Cell 7 211 217
2. F Balkwill A Mantovani 2001 Inflammation and cancer: back to Virchow? Lancet 357 539 545
3. T Blankenstein 2007 Do autochthonous tumors interfere with effector T cell responses? Semin Cancer Biol 17 267 274
4. C Boshoff R Weiss 2002 AIDS-related malignancies Nat Rev Cancer 2 373 382
5. RJ Buckanovich A Facciabene S Kim F Benencia D Sasaroli K Balint D Katsaros A O'Brien-Jenkins PA Gimotty G Coukos 2008 Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy Nat Med 14 28 36
6. FM Burnet 1970 The concept of immunological surveillance Prog Exp Tumor Res 13 1 27
7. O Casanovas DJ Hicklin G Bergers D Hanahan 2005 Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors Cancer Cell 8 299 309
8. LM Coussens WW Raymond G Bergers M Laig-Webster O Behrendtsen Z Werb GH Caughey D Hanahan 1999 Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis Genes Dev 13 1382 1397
9. LM Coussens CL Tinkle D Hanahan Z Werb 2000 MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis Cell 103 481 490
10. DO Croci MF Zacarias Fluck MJ Rico P Matar GA Rabinovich OG Scharovsky 2007 Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment Cancer Immunol Immunother 56 1687 1700
11. TJ Curiel G Coukos L Zou X Alvarez P Cheng P Mottram M Evdemon-Hogan JR Conejo-Garcia L Zhang M Burow Y Zhu S Wei I Kryczek B Daniel A Gordon L Myers A Lackner ML Disis KL Knutson L Chen W Zou 2004 Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 942 949
12. KE de Visser LM Coussens 2006 The inflammatory tumor microenvironment and its impact on cancer development Contrib Microbiol 13 118 137
13. KE de Visser A Eichten LM Coussens 2006 Paradoxical roles of the immune system during cancer development Nat Rev Cancer 6 24 37
14. KE de Visser LV Korets LM Coussens 2005 De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent Cancer Cell 7 411 423
15. KE de Visser LV Korets LM Coussens 2004 Early neoplastic progression is complement independent Neoplasia 6 768 776
16. PW Derksen X Liu F Saridin H van der Gulden J Zevenhoven B Evers JR van Beijnum AW Griffioen J Vink P Krimpenfort JL Peterse RD Cardiff A Berns J Jonkers 2006 Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis Cancer Cell 10 437 449
17. GP Dunn AT Bruce H Ikeda LJ Old RD Schreiber 2002 Cancer immunoediting: from immunosurveillance to tumor escape Nat Immunol 3 991 998
18. GP Dunn CM Koebel RD Schreiber 2006 Interferons, immunity and cancer immunoediting Nat Rev Immunol 6 836 848
19. GP Dunn LJ Old RD Schreiber 2004 The immunobiology of cancer immunosurveillance and immunoediting Immunity 21 137 148
20. AM Engel IM Svane J Rygaard O Werdelin 1997 MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice Scand J Immunol 45 463 470
21. SJ Engle I Ormsby S Pawlowski GP Boivin J Croft E Balish T Doetschman 2002 Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice Cancer Res 62 6362 6366
22. T Enzler S Gillessen JP Manis D Ferguson J Fleming FW Alt M Mihm G Dranoff 2003 Deficiencies of GM-CSF and interferon gamma link inflammation and cancer J Exp Med 197 1213 1219
23. C Fischer B Jonckx M Mazzone S Zacchigna S Loges L Pattarini E Chorianopoulos L Liesenborghs M Koch M De Mol M Autiero S Wyns S Plaisance L Moons N van Rooijen M Giacca JM Stassen M Dewerchin D Collen P Carmeliet 2007 Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels Cell 131 463 475
24. J Galon A Costes F Sanchez-Cabo A Kirilovsky B Mlecnik C Lagorce-Pages M Tosolini M Camus A Berger P Wind F Zinzindohoue P Bruneval PH Cugnenc Z Trajanoski WH Fridman F Pages 2006 Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 1960 1964
25. AI Garbe B Vermeer J Gamrekelashvili R von Wasielewski FR Greten AM Westendorf J Buer RM Schmid MP Manns F Korangy TF Greten 2006 Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses Cancer Res 66 508 516
26. M Girardi DE Oppenheim CR Steele JM Lewis E Glusac R Filler P Hobby B Sutton RE Tigelaar AC Hayday 2001 Regulation of cutaneous malignancy by gammadelta T cells Science 294 605 609
27. FR Greten L Eckmann TF Greten JM Park ZW Li LJ Egan MF Kagnoff M Karin 2004 IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 285 296
28. C Guerra AJ Schuhmacher M Canamero PJ Grippo L Verdaguer L Perez-Gallego P Dubus EP Sandgren M Barbacid 2007 Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice Cancer Cell 11 291 302
29. RA Gupta RN Dubois 2001 Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 Nat Rev Cancer 1 11 21
30. HT Khong NP Restifo 2002 Natural selection of tumor variants in the generation of "tumor escape" phenotypes Nat Immunol 3 999 1005
31. CM Koebel W Vermi JB Swann N Zerafa SJ Rodig LJ Old MJ Smyth RD Schreiber 2007 Adaptive immunity maintains occult cancer in an equilibrium state Nature 450 903 907
32. S Kusmartsev DI Gabrilovich 2006 Role of immature myeloid cells in mechanisms of immune evasion in cancer Cancer Immunol Immunother 55 237 245
33. EY Lin AV Nguyen RG Russell JW Pollard 2001 Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy J Exp Med 193 727 740
34. RJ Moore DM Owens G Stamp C Arnott F Burke N East H Holdsworth L Turner B Rollins M Pasparakis G Kollias F Balkwill 1999 Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis Nat Med 5 828 831
35. AF Ochsenbein P Klenerman U Karrer B Ludewig M Pericin H Hengartner RM Zinkernagel 1999 Immune surveillance against a solid tumor fails because of immunological ignorance Proc Natl Acad Sci USA 96 2233 2238
36. H Ohshima 2003 Genetic and epigenetic damage induced by reactive nitrogen species implications in carcinogenesis Toxicol Lett 140-141 99 104
37. CR Parish 2003 Cancer immunotherapy: the past, the present and the future Immunol Cell Biol 81 106 113
38. E Pikarsky RM Porat I Stein R Abramovitch S Amit S Kasem E Gutkovich-Pyest S Urieli-Shoval E Galun Y Ben-Neriah 2004 NF-kappaB functions as a tumour promoter in inflammation-associated cancer Nature 431 461 466
39. Z Qin T Blankenstein 2004 A cancer immunosurveillance controversy Nat Immunol 5 3 4
40. P Serafini C De Santo I Marigo S Cingarlini L Dolcetti G Gallina P Zanovello V Bronte 2004 Derangement of immune responses by myeloid suppressor cells Cancer Immunol Immunother 53 64 72
41. V Shankaran H Ikeda AT Bruce JM White PE Swanson LJ Old RD Schreiber 2001 IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature 410 1107 1111
42. CT Siegel K Schreiber SC Meredith GB Beck-Engeser DW Lancki CA Lazarski YX Fu DA Rowley H Schreiber 2000 Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein J Exp Med 191 1945 1956
43. L Soucek ER Lawlor D Soto K Shchors LB Swigart GI Evan 2007 Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors Nat Med 13 1211 1218
44. O Stutman 1974 Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice Science 183 534 536
45. TT Tan LM Coussens 2007 Humoral immunity, inflammation and cancer Curr Opin Immunol 19 209 216
46. ME van den Broek D Kagi F Ossendorp R Toes S Vamvakas WK Lutz CJ Melief RM Zinkernagel H Hengartner 1996 Decreased tumor surveillance in perforin-deficient mice J Exp Med 184 1781 1790
47. G Willimsky T Blankenstein 2005 Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance Nature 437 141 146
48. J Wyckoff W Wang EY Lin Y Wang F Pixley ER Stanley T Graf JW Pollard J Segall J Condeelis 2004 A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors Cancer Res 64 7022 7029
49. P Yu DA Rowley YX Fu H Schreiber 2006 The role of stroma in immune recognition and destruction of well-established solid tumors Curr Opin Immunol 18 226 231
50. W Zou 2005 Immunosuppressive networks in the tumour environment and their therapeutic relevance Nat Rev Cancer 5 263 274